Key Points
- COO John Gallagher sold 6,383 shares at an average of $34.82 for $222,256.06, cutting his stake by 16.32% to 32,721 shares valued at about $1.14 million.
- Trupanion missed quarterly EPS estimates ($0.13 reported vs. $0.89 expected) while revenue grew 12% year‑over‑year to $366.92 million.
- Several large institutions (e.g., Millennium, Wellington, Two Sigma) increased holdings, yet analysts maintain a consensus Hold rating with a $54 price target.
Trupanion, Inc. (NASDAQ:TRUP - Get Free Report) COO John Gallagher sold 6,383 shares of the stock in a transaction on Friday, November 28th. The stock was sold at an average price of $34.82, for a total transaction of $222,256.06. Following the transaction, the chief operating officer directly owned 32,721 shares in the company, valued at $1,139,345.22. The trade was a 16.32% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.
Trupanion Price Performance
Shares of NASDAQ:TRUP opened at $34.03 on Tuesday. The stock has a market capitalization of $1.47 billion, a P/E ratio of 130.89 and a beta of 1.82. The business has a 50-day moving average of $40.53 and a two-hundred day moving average of $45.89. Trupanion, Inc. has a fifty-two week low of $31.00 and a fifty-two week high of $57.88. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.69 and a quick ratio of 1.69.
Trupanion (NASDAQ:TRUP - Get Free Report) last issued its quarterly earnings data on Thursday, November 6th. The financial services provider reported $0.13 EPS for the quarter, missing analysts' consensus estimates of $0.89 by ($0.76). Trupanion had a net margin of 0.81% and a return on equity of 3.31%. The company had revenue of $366.92 million for the quarter, compared to analyst estimates of $361.58 million. During the same period in the prior year, the company posted $0.03 EPS. The business's revenue was up 12.0% on a year-over-year basis. Trupanion has set its Q4 2025 guidance at EPS. FY 2025 guidance at EPS. On average, equities research analysts predict that Trupanion, Inc. will post 0.13 EPS for the current fiscal year.
Institutional Trading of Trupanion
A number of hedge funds have recently bought and sold shares of TRUP. Millennium Management LLC increased its holdings in shares of Trupanion by 185.8% during the 3rd quarter. Millennium Management LLC now owns 619,003 shares of the financial services provider's stock worth $26,790,000 after purchasing an additional 402,421 shares during the period. Wellington Management Group LLP grew its position in Trupanion by 13.2% during the first quarter. Wellington Management Group LLP now owns 2,491,227 shares of the financial services provider's stock worth $92,848,000 after buying an additional 290,788 shares in the last quarter. Jacobs Levy Equity Management Inc. increased its stake in Trupanion by 2,029.0% during the first quarter. Jacobs Levy Equity Management Inc. now owns 303,550 shares of the financial services provider's stock valued at $11,313,000 after acquiring an additional 289,292 shares during the period. Two Sigma Investments LP raised its holdings in Trupanion by 3,201.0% in the 3rd quarter. Two Sigma Investments LP now owns 224,433 shares of the financial services provider's stock valued at $9,713,000 after acquiring an additional 217,634 shares in the last quarter. Finally, Hosking Partners LLP lifted its position in shares of Trupanion by 86.9% in the 1st quarter. Hosking Partners LLP now owns 397,656 shares of the financial services provider's stock worth $14,821,000 after acquiring an additional 184,936 shares during the period.
Analyst Upgrades and Downgrades
A number of research firms have recently commented on TRUP. Wall Street Zen raised shares of Trupanion from a "hold" rating to a "buy" rating in a research report on Saturday, November 8th. Stifel Nicolaus dropped their target price on shares of Trupanion from $45.00 to $42.00 and set a "hold" rating on the stock in a report on Tuesday, November 18th. Piper Sandler boosted their target price on shares of Trupanion from $62.00 to $67.00 and gave the stock an "overweight" rating in a research report on Friday, August 8th. Weiss Ratings reaffirmed a "sell (d+)" rating on shares of Trupanion in a research report on Tuesday, November 25th. Finally, Cantor Fitzgerald raised Trupanion to a "hold" rating in a research report on Wednesday, August 13th. Two investment analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus price target of $54.00.
Check Out Our Latest Analysis on Trupanion
About Trupanion
(
Get Free Report)
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
Further Reading
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
